DK1095059T3 - Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse - Google Patents
Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelseInfo
- Publication number
- DK1095059T3 DK1095059T3 DK99933284T DK99933284T DK1095059T3 DK 1095059 T3 DK1095059 T3 DK 1095059T3 DK 99933284 T DK99933284 T DK 99933284T DK 99933284 T DK99933284 T DK 99933284T DK 1095059 T3 DK1095059 T3 DK 1095059T3
- Authority
- DK
- Denmark
- Prior art keywords
- chips
- staphylococcus
- chemotaxia
- inhibitory protein
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Compounds Of Unknown Constitution (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL1009614 | 1998-07-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1095059T3 true DK1095059T3 (da) | 2006-10-02 |
Family
ID=19767471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99933284T DK1095059T3 (da) | 1998-07-10 | 1999-07-12 | Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20050143307A1 (da) |
| EP (1) | EP1095059B1 (da) |
| JP (1) | JP2002520336A (da) |
| KR (1) | KR20010053290A (da) |
| CN (1) | CN1309662A (da) |
| AT (1) | ATE328898T1 (da) |
| AU (1) | AU4935999A (da) |
| BG (1) | BG105120A (da) |
| BR (1) | BR9911944A (da) |
| CA (1) | CA2333898A1 (da) |
| CY (1) | CY1105343T1 (da) |
| DE (1) | DE69931784T2 (da) |
| DK (1) | DK1095059T3 (da) |
| ES (1) | ES2270609T3 (da) |
| HU (1) | HUP0102975A2 (da) |
| IL (1) | IL140768A0 (da) |
| NO (1) | NO20010140L (da) |
| NZ (1) | NZ509051A (da) |
| PL (1) | PL345452A1 (da) |
| PT (1) | PT1095059E (da) |
| WO (1) | WO2000002913A1 (da) |
| ZA (1) | ZA200100092B (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1095059T3 (da) * | 1998-07-10 | 2006-10-02 | Alligator Bioscience Ab Publ | Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse |
| EP1118663A1 (en) | 2000-01-07 | 2001-07-25 | Universiteit Utrecht | Nucleic acids encoding chemotaxis inhibitory polypeptides |
| US20020086292A1 (en) | 2000-12-22 | 2002-07-04 | Shigeaki Harayama | Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules |
| WO2003006048A1 (en) * | 2001-07-11 | 2003-01-23 | Jari Pharmaceuticals B.V. | Combination of chips (chemotaxis inhibiting protein from staphylococcus aureus)-based compounds |
| DE602004031836D1 (de) * | 2003-07-08 | 2011-04-28 | Umc Utrecht Holding Bv | Therapeutische verwendung von lpi, einem inhibitor des lectinwegs in staphylokokken bei entzündungskrankheiten |
| EP1586583A3 (en) * | 2004-04-16 | 2005-11-16 | Alligator Bioscience AB (publ) | Compounds that block C5a complement receptor and their use in therapy |
| US20090186111A1 (en) | 2004-07-26 | 2009-07-23 | Zeev Trainin | Novel Bacteria and Pharmaceutically Active Products Obtained Therefrom |
| GB2432366B (en) * | 2005-11-19 | 2007-11-21 | Alligator Bioscience Ab | A method for in vitro molecular evolution of protein function |
| GB0607798D0 (en) * | 2006-04-20 | 2006-05-31 | Alligator Bioscience Ab | Novel polypeptides and use thereof |
| GB0905790D0 (en) | 2009-04-03 | 2009-05-20 | Alligator Bioscience Ab | Novel polypeptides and use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4772584A (en) * | 1986-05-23 | 1988-09-20 | Cleary Paul P | Inhibitor of C5a-mediated chemotaxis |
| EP0669989A1 (en) * | 1991-08-22 | 1995-09-06 | Washington University | Polynucleotide probes for salmonella |
| US5514555A (en) * | 1993-03-12 | 1996-05-07 | Center For Blood Research, Inc. | Assays and therapeutic methods based on lymphocyte chemoattractants |
| US5514455A (en) * | 1994-07-08 | 1996-05-07 | Union Carbide Chemicals & Plastics Technology Corporation | Film extruded from an in situ blend of ethylene copolymers |
| US5817476A (en) * | 1995-06-07 | 1998-10-06 | Genetics Institute, Inc. | Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins |
| US7153655B2 (en) * | 1998-06-16 | 2006-12-26 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence |
| DK1095059T3 (da) * | 1998-07-10 | 2006-10-02 | Alligator Bioscience Ab Publ | Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse |
| JP3722194B2 (ja) * | 1999-05-20 | 2005-11-30 | セイコーエプソン株式会社 | 画像表示システム |
| EP1118663A1 (en) * | 2000-01-07 | 2001-07-25 | Universiteit Utrecht | Nucleic acids encoding chemotaxis inhibitory polypeptides |
| US6958213B2 (en) * | 2000-12-12 | 2005-10-25 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function |
| US20020086292A1 (en) * | 2000-12-22 | 2002-07-04 | Shigeaki Harayama | Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules |
| US7262012B2 (en) * | 2002-05-17 | 2007-08-28 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function using varied exonuclease digestion in two polynucleotide populations |
-
1999
- 1999-07-12 DK DK99933284T patent/DK1095059T3/da active
- 1999-07-12 AU AU49359/99A patent/AU4935999A/en not_active Abandoned
- 1999-07-12 NZ NZ509051A patent/NZ509051A/xx unknown
- 1999-07-12 EP EP99933284A patent/EP1095059B1/en not_active Expired - Lifetime
- 1999-07-12 HU HU0102975A patent/HUP0102975A2/hu unknown
- 1999-07-12 JP JP2000559142A patent/JP2002520336A/ja active Pending
- 1999-07-12 IL IL14076899A patent/IL140768A0/xx unknown
- 1999-07-12 KR KR1020007015012A patent/KR20010053290A/ko not_active Application Discontinuation
- 1999-07-12 BR BR9911944-7A patent/BR9911944A/pt not_active IP Right Cessation
- 1999-07-12 AT AT99933284T patent/ATE328898T1/de not_active IP Right Cessation
- 1999-07-12 PT PT99933284T patent/PT1095059E/pt unknown
- 1999-07-12 CA CA002333898A patent/CA2333898A1/en not_active Abandoned
- 1999-07-12 PL PL99345452A patent/PL345452A1/xx unknown
- 1999-07-12 DE DE69931784T patent/DE69931784T2/de not_active Expired - Lifetime
- 1999-07-12 CN CN99808416A patent/CN1309662A/zh active Pending
- 1999-07-12 WO PCT/NL1999/000442 patent/WO2000002913A1/en active IP Right Grant
- 1999-07-12 ES ES99933284T patent/ES2270609T3/es not_active Expired - Lifetime
-
2001
- 2001-01-04 ZA ZA200100092A patent/ZA200100092B/en unknown
- 2001-01-08 BG BG105120A patent/BG105120A/xx unknown
- 2001-01-09 NO NO20010140A patent/NO20010140L/no unknown
-
2005
- 2005-02-22 US US11/063,324 patent/US20050143307A1/en not_active Abandoned
-
2006
- 2006-09-06 CY CY20061101273T patent/CY1105343T1/el unknown
-
2007
- 2007-03-27 US US11/691,745 patent/US20080242605A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ509051A (en) | 2003-01-31 |
| PL345452A1 (en) | 2001-12-17 |
| EP1095059A1 (en) | 2001-05-02 |
| US20080242605A1 (en) | 2008-10-02 |
| ES2270609T3 (es) | 2007-04-01 |
| BG105120A (en) | 2001-11-30 |
| US20050143307A1 (en) | 2005-06-30 |
| PT1095059E (pt) | 2006-10-31 |
| KR20010053290A (ko) | 2001-06-25 |
| AU4935999A (en) | 2000-02-01 |
| NO20010140D0 (no) | 2001-01-09 |
| NO20010140L (no) | 2001-03-01 |
| EP1095059B1 (en) | 2006-06-07 |
| ZA200100092B (en) | 2001-07-23 |
| WO2000002913A1 (en) | 2000-01-20 |
| CN1309662A (zh) | 2001-08-22 |
| IL140768A0 (en) | 2002-02-10 |
| JP2002520336A (ja) | 2002-07-09 |
| DE69931784T2 (de) | 2007-06-14 |
| DE69931784D1 (de) | 2006-07-20 |
| BR9911944A (pt) | 2001-09-25 |
| HUP0102975A2 (hu) | 2001-11-28 |
| WO2000002913B1 (en) | 2000-03-30 |
| CA2333898A1 (en) | 2000-01-20 |
| ATE328898T1 (de) | 2006-06-15 |
| CY1105343T1 (el) | 2010-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051082L (no) | Antimikrobielle kinoloner, deres sammensetninger og anvendelser | |
| EA200301115A1 (ru) | Кристаллические формы азитромицина | |
| SE0102315D0 (sv) | Compounds | |
| WO2003005999A3 (en) | Methods of treating cytokine mediated diseases | |
| GB0125222D0 (en) | Composition for the treatment of microbial infections | |
| BR0014470A (pt) | Inibidores de fab i | |
| NO20052362D0 (no) | Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner | |
| DE60325498D1 (de) | 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen | |
| TR200003170T2 (tr) | MRS inhibitörleri ve bakterisid olarak kullanılan quinolone'lar | |
| CY1105343T1 (el) | Σταφυλοκοκκικη πρωτεϊνη αναστολης του χημειοτακτισμου (chips) και η χρηση αυτης | |
| ATE433963T1 (de) | Fab-i inhibitoren | |
| NZ510369A (en) | Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection | |
| ATE335499T1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
| DE60310767D1 (de) | PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN | |
| YU102503A (sh) | Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva | |
| DE60105614D1 (de) | Oxazinochinolone für die behandlung viraler infektionen | |
| ATE335739T1 (de) | Cak inhibitoren und deren verwendungen | |
| AU2003210850A1 (en) | N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof | |
| DK1439840T3 (da) | Antibakterielle monobactam-forbindelser og fremgangsmåder til anvendelse heraf | |
| PT1358182E (pt) | Derivados de diazocinas e sua utilizacao como inibidores de triptase | |
| DE60326710D1 (de) | Trizyklische antibakterielle makrolidderivate | |
| SE0002045D0 (sv) | New use | |
| DE60324466D1 (de) | Zusammensetzungfür die behandlung von mycobakterieninfektionen | |
| SE0200119D0 (sv) | Novel compounds |